Top

Published in:

01-06-2015 | Research Article

Associations of polymorphisms in microRNAs with female breast cancer risk in Chinese population

Authors: Bangshun He, Yuqin Pan, Yeqiong Xu, Qiwen Deng, Huling Sun, Tianyi Gao, Shukui Wang

Published in: Tumor Biology | Issue 6/2015

Abstract

Polymorphisms in microRNA (miRNA) have been discussed to be associated with breast cancer risk; however, the conclusions were always inconsistent in different ethnicities. This case–control study enrolled 450 breast cancer cases, and 450 health controls was carried out to investigate the association between six polymorphisms in miRNAs and breast cancer risk. Sequenom MassARRAY was used to detect the polymorphisms in miRNAs, and the immunohistochemistry assay was applied to detect the expression of estrogen receptor (ER) and progesterone receptor (PR) in cancer tissue. The data showed that the 3746444 GG was associated with increased breast cancer risk (adjusted odds ratio (OR) = 1.71, 95 % confidence interval (CI) = 1.16–2.52) and that rs2292832 CC (adjusted OR = 0.54, 95 % CI = 0.34–0.85) was associated with decreased breast cancer risk. In addition, menopausal status subgroup analysis revealed that rs3746444 GG (adjusted OR = 2.34, 95 % CI = 1.31–4.15) and GA/GG (adjusted OR = 1.60, 95 % CI = 1.08–2.37) genotypes were associated with increased breast cancer risk for the subgroup of women with premenopausal status, respectively. Moreover, rs2910164 GG (adjusted OR = 1.84, 95 % CI = 1.07–3.15) and CG/GG (adjusted OR = 1.47, 95 % CI = 1.01–2.15) genotypes were associated with increased breast cancer risk in the postmenopausal status subcohort, respectively. Furthermore, rs3746444 AG (adjusted OR = 1.61, 95 % CI = 1.06–2.45) and AG/GG (adjusted OR = 1.49, 95 % CI = 1.02–2.18) genotypes were observed to be associated with increased risk of lymph node involvement and breast cancer with negative PR expression, separately. In short, rs3746444 was associated with breast cancer risk, especially for women with premenopausal status, and rs2910164 CG and CG/GG genotypes were associated with breast cancer risk for the women with premenopausal status.

Available only for authorised users

Benz CC. Impact of aging on the biology of breast cancer. Crit Rev Oncol Hematol. 2008;66:65–74.CrossRefPubMed

Lee RC, Feinbaum RL, Ambros V. The C. elegans heterochronic gene lin-4 encodes small rnas with antisense complementarity to lin-14. Cell. 1993;75:843–54.CrossRefPubMed

Bartel DP. Micrornas: genomics, biogenesis, mechanism, and function. Cell. 2004;116:281–97.CrossRefPubMed

Esquela-Kerscher A, Slack FJ. Oncomirs—micrornas with a role in cancer. Nat Rev Cancer. 2006;6:259–69.CrossRefPubMed

Chen JF, Mandel EM, Thomson JM, Wu Q, Callis TE, Hammond SM, et al. The role of microrna-1 and microrna-133 in skeletal muscle proliferation and differentiation. Nat Genet. 2006;38:228–33.CrossRefPubMed

Brennecke J, Hipfner DR, Stark A, Russell RB, Cohen SM. Bantam encodes a developmentally regulated microrna that controls cell proliferation and regulates the proapoptotic gene hid in drosophila. Cell. 2003;113:25–36.CrossRefPubMed

Cimmino A, Calin GA, Fabbri M, Iorio MV, Ferracin M, Shimizu M, et al. Mir-15 and mir-16 induce apoptosis by targeting bcl2. Proc Natl Acad Sci U S A. 2005;102:13944–9.CrossRefPubMedPubMedCentral

Hatfield SD, Shcherbata HR, Fischer KA, Nakahara K, Carthew RW, Ruohola-Baker H. Stem cell division is regulated by the microrna pathway. Nature. 2005;435:974–8.CrossRefPubMed

Calin GA, Sevignani C, Dumitru CD, Hyslop T, Noch E, Yendamuri S, et al. Human microrna genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci U S A. 2004;101:2999–3004.CrossRefPubMedPubMedCentral

10.

Takamizawa J, Konishi H, Yanagisawa K, Tomida S, Osada H, Endoh H, et al. Reduced expression of the let-7 micrornas in human lung cancers in association with shortened postoperative survival. Cancer Res. 2004;64:3753–6.CrossRefPubMed

11.

Iwai N, Naraba H. Polymorphisms in human pre-mirnas. Biochem Biophys Res Commun. 2005;331:1439–44.CrossRefPubMed

12.

Ryan BM, Robles AI, Harris CC. Genetic variation in microrna networks: the implications for cancer research. Nat Rev Cancer. 2010;10:389–402.CrossRefPubMedPubMedCentral

13.

He B, Pan Y, Cho WC, Xu Y, Gu L, Nie Z, et al. The association between four genetic variants in micrornas (rs11614913, rs2910164, rs3746444, rs2292832) and cancer risk: evidence from published studies. PLoS One. 2012;7:e49032.CrossRefPubMedPubMedCentral

14.

Catucci I, Yang R, Verderio P, Pizzamiglio S, Heesen L, Hemminki K, et al. Evaluation of snps in mir-146a, mir196a2 and mir-499 as low-penetrance alleles in german and italian familial breast cancer cases. Hum Mutat. 2010;31:E1052–7.CrossRefPubMed

15.

Jedlinski DJ, Gabrovska PN, Weinstein SR, Smith RA, Griffiths LR. Single nucleotide polymorphism in hsa-mir-196a-2 and breast cancer risk: a case control study. Twin Res Hum Genet. 2011;14:417–21.CrossRefPubMed

16.

Hu Z, Liang J, Wang Z, Tian T, Zhou X, Chen J, et al. Common genetic variants in pre-micrornas were associated with increased risk of breast cancer in chinese women. Hum Mutat. 2009;30:79–84.CrossRefPubMed

17.

Hoffman AE, Zheng T, Yi C, Leaderer D, Weidhaas J, Slack F, et al. Microrna mir-196a-2 and breast cancer: a genetic and epigenetic association study and functional analysis. Cancer Res. 2009;69:5970–7.CrossRefPubMedPubMedCentral

18.

Zhang M, Jin M, Yu Y, Zhang S, Wu Y, Liu H, et al. Associations of mirna polymorphisms and female physiological characteristics with breast cancer risk in chinese population. Eur J Cancer Care (Engl). 2012;21:274–80.CrossRef

19.

Gabriel S, Ziaugra L, Tabbaa D. Snp genotyping using the sequenom massarray iplex platform. Curr Protoc Hum Genet 2009;Chapter 2:Unit 2 12.

20.

Thomas RK, Baker AC, Debiasi RM, Winckler W, Laframboise T, Lin WM, et al. High-throughput oncogene mutation profiling in human cancer. Nat Genet. 2007;39:347–51.CrossRefPubMed

21.

Gul AE, Keser SH, Barisik NO, Kandemir NO, Cakir C, Sensu S, et al. The relationship of cerb b 2 expression with estrogen receptor and progesterone receptor and prognostic parameters in endometrial carcinomas. Diagn Pathol. 2010;5:13.CrossRefPubMedPubMedCentral

22.

Ma XP, Zhang T, Peng B, Yu L, de Jiang K. Association between microrna polymorphisms and cancer risk based on the findings of 66 case-control studies. PLoS One. 2013;8:e79584.CrossRefPubMedPubMedCentral

23.

Srivastava K, Srivastava A. Comprehensive review of genetic association studies and meta-analyses on mirna polymorphisms and cancer risk. PLoS One. 2012;7:e50966.CrossRefPubMedPubMedCentral

24.

Chen QH, Wang QB, Zhang B. Ethnicity modifies the association between functional microrna polymorphisms and breast cancer risk: a huge meta-analysis. Tumour Biol. 2014;35:529–43.CrossRefPubMed

25.

Xu Y, Gu L, Pan Y, Li R, Gao T, Song G, et al. Different effects of three polymorphisms in micrornas on cancer risk in asian population: evidence from published literatures. PLoS One. 2013;8:e65123.CrossRefPubMedPubMedCentral

26.

Ma F, Zhang P, Lin D, Yu D, Yuan P, Wang J, et al. There is no association between microrna gene polymorphisms and risk of triple negative breast cancer in a chinese han population. PLoS One. 2013;8:e60195.CrossRefPubMedPubMedCentral

27.

Alshatwi AA, Shafi G, Hasan TN, Syed NA, Al-Hazzani AA, Alsaif MA, et al. Differential expression profile and genetic variants of micrornas sequences in breast cancer patients. PLoS One. 2012;7:e30049.CrossRefPubMedPubMedCentral

28.

Omrani M, Hashemi M, Eskandari-Nasab E, Hasani SS, Mashhadi MA, Arbabi F, et al. Hsa-mir-499 rs3746444 gene polymorphism is associated with susceptibility to breast cancer in an iranian population. Biomark Med. 2014;8:259–67.CrossRefPubMed

29.

Landgraf P, Rusu M, Sheridan R, Sewer A, Iovino N, Aravin A, et al. A mammalian microrna expression atlas based on small rna library sequencing. Cell. 2007;129:1401–14.CrossRefPubMedPubMedCentral

30.

Wang AX, Xu B, Tong N, Chen SQ, Yang Y, Zhang XW, et al. Meta-analysis confirms that a common g/c variant in the pre-mir-146a gene contributes to cancer susceptibility and that ethnicity, gender and smoking status are risk factors. Genet Mol Res. 2012;11:3051–62.CrossRefPubMed

31.

Xu T, Zhu Y, Wei QK, Yuan Y, Zhou F, Ge YY, et al. A functional polymorphism in the mir-146a gene is associated with the risk for hepatocellular carcinoma. Carcinogenesis. 2008;29:2126–31.CrossRefPubMed

32.

Jazdzewski K, Murray EL, Franssila K, Jarzab B, Schoenberg DR, de la Chapelle A. Common snp in pre-mir-146a decreases mature mir expression and predisposes to papillary thyroid carcinoma. Proc Natl Acad Sci U S A. 2008;105:7269–74.CrossRefPubMedPubMedCentral

33.

Bhaumik D, Scott GK, Schokrpur S, Patil CK, Campisi J, Benz CC. Expression of microrna-146 suppresses nf-kappab activity with reduction of metastatic potential in breast cancer cells. Oncogene. 2008;27:5643–7.CrossRefPubMedPubMedCentral

Title: Associations of polymorphisms in microRNAs with female breast cancer risk in Chinese population
Authors: Bangshun He
Yuqin Pan
Yeqiong Xu
Qiwen Deng
Huling Sun
Tianyi Gao
Shukui Wang
Publication date: 01-06-2015
Publisher: Springer Netherlands
Published in: Tumor Biology / Issue 6/2015
Print ISSN: 1010-4283
Electronic ISSN: 1423-0380
DOI: https://doi.org/10.1007/s13277-015-3102-2

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 6/2015

Autophagy and its function in radiosensitivity

Exosomal onco-miRs from serum of patients with adenocarcinoma of the esophagus: comparison of miRNA profiles of exosomes and matching tumor

Overexpression of SMYD3 and matrix metalloproteinase-9 are associated with poor prognosis of patients with gastric cancer

Baicalein induces human osteosarcoma cell line MG-63 apoptosis via ROS-induced BNIP3 expression

Radioimmunotherapy—a potential novel tool for pancreatic cancer therapy?

RETRACTED ARTICLE: Urinary parameters predictive and electrolyte disturbances of cisplatin-induced acute renal associated with cancer as a critical target of the chemotherapeutic agent in patients with solid tumors

Keynote webinar | Spotlight on antibody–drug conjugates in cancer